NIFTY, Intraday Tips, NSE, News, Mutual Fund, Commodity, Currency, World Market, Finance, Economic, BSE, Wealth, NPS, IPO, Portfolio, MCX, Investment Guru

05-10-2021 12:48 PM | Source: Angel Broking Ltd

Cipla signs royalty-free Agreement with Eli Lilly, USA by Mr. Yash Gupta, Angel Broking Ltd

News By Tags | #5948 #416 #607 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Below are Quote on Cipla signs royalty-free Agreement with Eli Lilly, USA by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd

Cipla Limited announced that the company has signed a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company, USA for the manufacture and commercialization of the drug baricitinib for Covid-19 indication. Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO), Ministry of Health, India for use in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). This collaboration is a step further in Cipla’s efforts to enhance access to critical treatments for patients affected by the pandemic.

This can be a very good product for the company, a lot of things will depend on how the covid 19 pandemic 2^nd or 3^rd wave spread in India.

Above views are of the author and not of the website kindly read disclaimer

IGI Logo

Cipla signs royalty-free Agreement with Eli Lilly, USA by Mr. Yash Gupta, Angel Broking Ltd

Top News

Tag News

More News